But the company is not wavering in its plans to dramatically hike the price of its COVID ... updated vaccines—to be in the range of $110 to $130," Garay said. In March, Moderna CEO Stéphane ...
The number of people with COVID-19 has been rising rapidly in China in recent weeks, and there are concerns that the ...
Moderna maintained its full-year guidance of a minimum of $5 billion in revenue from its Covid vaccine, which will come from signed government contracts for the shot. CEO Stéphane Bancel said ...
The company did not change its forecast of $5 billion in COVID vaccine sales for the year based on advance purchase agreements. But Moderna said it was in discussions about new contracts with ...
Moderna hits roadblock in flu Moderna CEO defends Covid vaccine price hike in Senate grilling Related: Moderna CEO defends Covid vaccine price hike in Senate grilling ...
The logistics involved will become more costly and complex than when Moderna was selling directly to national governments. But the company plans on increasing the price of its vaccine to as much ...
This has been worrying investors, weighing on the stock price. But what if I told you the coronavirus vaccine may be only the start of the Moderna story? This innovative biotech has branched out ...
That simple, original series of vaccines we got—two doses spaced three weeks apart of either Moderna or Pfizer monovalent COVID vaccines—no longer exist. The monovalent (that’s what they ...
Moderna Therapeutics CEO Stéphane Bancel joins Yahoo Finance Live to discuss first-quarter earnings, COVID-19 vaccine sales, profit growth, and the outlook for the biotechnology company’s RSV ...
By Campbell Robertson Early in the pandemic, scientists began testing an old TB vaccine against the coronavirus ... in 2021 because of safety concerns. Moderna has paid $400 million to the ...
Moderna has pledged never to enforce its coronavirus vaccine patents ... initiatives aimed at increasing vaccine manufacturing capacity in low- and middle-income countries. “It’s a very big ...
A vial of the Moderna coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8 ...
